Luu Brendan, Chief Business Officer at Enanta Pharmaceuticals Inc. ($ENTA), made one open market sale of company shares in the last year, totaling nearly $20,000. His most recent sale occurred on December 5, 2025. These sales rank 11,046th among 11,678 individual insiders, far below the average of $8.6 million per seller and 6.4 transactions. Brendan Luu reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | F | Common Stock | 3257 | $14.25 | 41,634.0000 | 29,019,344 | 7.26% | 0.01% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Common Stock | 4987 | $0.00 | 44,891.0000 | 29,019,344 | 12.50% | 0.02% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Common Stock | 1575 | $0.00 | 39,904.0000 | 29,019,344 | 4.11% | 0.01% |
| Dec. 5, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | S | Common Stock | 1394 | $14.23 | 38,329.0000 | 28,862,601 | 3.51% | 0.00% |
| Dec. 1, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | F | Common Stock | 498 | $14.12 | 39,723.0000 | 28,862,601 | 1.24% | 0.00% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 28,862,601 | 9999.99% | 0.31% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Common Stock | 7500 | $0.00 | 43,547.0000 | 0 | 20.81% | 0.00% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | F | Common Stock | 3326 | $5.59 | 40,221.0000 | 0 | 7.64% | 0.00% |
| Dec. 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | S | Common Stock | 2283 | $8.06 | 36,047.0000 | 0 | 5.96% | 0.00% |
| Dec. 1, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | F | Common Stock | 753 | $8.60 | 38,330.0000 | 0 | 1.93% | 0.00% |
| Nov. 27, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | F | Common Stock | 973 | $12.41 | 39,083.0000 | 0 | 2.43% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luu Brendan | Chief Business Officer | A | Common Stock | 3320 | $0.00 | 40,056.0000 | 0 | 9.04% | 0.00% |